Intelligent Oncology2026，Vol.2Issue(2)：P.87-99,13.DOI:10.1016/j.intonc.2026.100053
Advancing precision oncology through hNQO1-activatable NIR-II probes:Integrating molecular imaging with artificial intelligence
Bamise I.Egbewole 1Emmanuel O.Oisakede 2Eghosasere Egbon 3Oluwakemi Jumoke Bello 4Claret Chinenyenwa Analikwu 5David B.Olawade6
作者信息
- 1. Department of Chemistry,Virginia Tech University,Blacksburg VA 24061,United States
- 2. Department of Clinical Oncology,Leeds Teaching Hospitals NHS Trust,Leeds LS97TF,United Kingdom Department of Health Research,University of Leeds,Leeds LS29JT,United Kingdom
- 3. Department of Tissue Engineering and Regenerative Medicine,Faculty of Life Science Engineering,FH Technikum,Vienna 1200,Austria
- 4. The Clinical Research Centre,The London Clinic,London W1G 6BW,United Kingdom
- 5. Department of Microbiology,Frimley Health NHS Foundation Trust,Surrey GU167UJ,United Kingdom
- 6. Department of Allied and Public Health,School of Health,Sport and Bioscience,University of East London,London E162RD,United Kingdom Department of Research and Innovation,Medway NHS Foundation Trust,Gillingham ME75NY,United Kingdom
- 折叠
摘要
关键词
hNQO1-activatable probes/NIR-II fluorescence imaging/Precision oncology/Tumor-targeted imaging/Artificial intelligence分类
医药卫生引用本文复制引用
Bamise I.Egbewole,Emmanuel O.Oisakede,Eghosasere Egbon,Oluwakemi Jumoke Bello,Claret Chinenyenwa Analikwu,David B.Olawade..Advancing precision oncology through hNQO1-activatable NIR-II probes:Integrating molecular imaging with artificial intelligence[J].Intelligent Oncology,2026,2(2):P.87-99,13.
